0

Global Primary Biliary Cholangitis Therapeutics Market 2019-2023

  • Published: Jun 2019
  • Pages: 131
  • SKU: IRTNTR31508
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The global primary biliary cholangitis (PBC) therapeutics market size will grow by USD 241.28 million during 2019-2023. The PBC therapeutics market report provides a detailed analysis of the market by product (OCALIVA, Ursodiol, and others) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Abbott Laboratories, Allergan Plc, Eli Lilly and Co., Intercept Pharmaceuticals Inc., and Takeda Pharmaceutical Co. Ltd.

A few of the key findings from this global primary biliary cholangitis therapeutics market analysis report are summarized below

Primary Biliary Cholangitis Therapeutics Market

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the PBC therapeutics market report.

Get a FREE sample now!

Global Primary Biliary Cholangitis Therapeutics Market Overview

There is a dire need for curative therapy for primary biliary cholangitis across the world. This is because of the recurring nature of the disease. Currently, the only cure for the condition is a liver transplant. This method of treatment makes it difficult for patients to lead a normal life even with post-surgery treatment. This has resulted in research on stem cell transplantation to replace destroyed cells in the bile duct. Although research on regenerative therapy is in its nascent stage, this trend will add significant value to the growth of the global primary biliary cholangitis therapeutics market during 2019-2023.

The growing awareness campaigns to reduce further complications in the primary biliary cholangitis indication is one of the key market growth drivers. The asymptomatic nature of the condition causes a delay in diagnosis in most of the cases. Also, the majority of the population is not aware of the symptoms of indications. Many vendors leveraged on this situation and started organizing awareness campaigns. Various non-profit organizations are also running awareness programs and funding research on novel therapies to treat the condition. These factors will increase the sales of primary biliary cholangitis therapeutics and contribute to the growth of the market, which will register a CAGR of close to 10% during the forecast period.

Top Primary Biliary Cholangitis Therapeutics Companies Covered in this Market Research Report

The global primary biliary cholangitis therapeutics market is concentrated. The PBC therapeutics market report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. The will help clients in improving their market positions. It also provides a detailed analysis of the upcoming primary biliary cholangitis therapeutics market trends and challenges that will influence market growth. The research will help companies in creating effective strategies to leverage the upcoming market growth opportunities.

The report offers a detailed analysis of many leading Primary Biliary Cholangitis Therapeutics companies, including:

  • Abbott Laboratories
  • Allergan Plc
  • Eli Lilly and Co.
  • Intercept Pharmaceuticals Inc.
  • Takeda Pharmaceutical Co. Ltd.

Primary Biliary Cholangitis Therapeutics Market Segmentation Based on Product

  • OCALIVA
  • Ursodiol
  • Others

OCALIVA held the largest market share in 2018. It will maintain its dominance in 2023 as well. OCALIVA was developed to treat various liver-related indications. It is currently the most preferred drug to treat primary biliary cholangitis owing to its strong efficacy to target cells compared with other available drugs in the market.

Primary Biliary Cholangitis Therapeutics Market Segmentation Based on Geographic Region

  • APAC
  • Europe
  • North America
  • ROW

North America has a high prevalence of primary biliary cholangitis indication. Therefore, the sales of primary biliary cholangitis therapeutics have been high in the region. These factors rendered the region the highest market shareholder in 2018. The sales of drugs for primary biliary cholangitis indication were the highest in the US. The demand for therapeutics as a treatment option will increase in North America during the forecast period. Such factors will aid the region in maintaining its dominance during the forecast period.

Key Highlights of the Global Primary Biliary Cholangitis Therapeutics Market Forecast Report for the Period 2019-2023

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the primary biliary cholangitis therapeutics market during the next five years
  • Precise estimation of the global primary biliary cholangitis therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the primary biliary cholangitis therapeutics industry across APAC, Europe, North America, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details of factors that will challenge the growth of primary biliary cholangitis therapeutics companies

We can help! Our analysts can customize the PBC therapeutics market research report to meet your requirements. Get in touch

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • OCALIVA - Market size and forecast 2018-2023
  • Ursodiol - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Strong pipeline
  • Increasing drug designations
  • Advent of regenerative therapy

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Allergan Plc
  • Eli Lilly and Co.
  • Intercept Pharmaceuticals Inc.
  • Takeda Pharmaceutical Co. Ltd.

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>